Literature DB >> 932020

Purification of human erythrocyte adenosine deaminase by affinity column chromatography.

W P Schrader, A R Stacy, B Pollara.   

Abstract

Adenosine deaminase (adenosine aminohydrolase EC 3.5.4.4) has been purified 468,000-fold from pooled human erythrocytes. The procedure developed was used to isolate the enzyme from up to 23 liters of packed erythrocytes at one time. An easily prepared affinity column bed material employing adenosine as the ligand was used as the final step in the purification. During elution from the affinity column there was approximately a 3:1 partition of adenosine deaminase between gel bed and column buffer. There was no apparent difference in the partitioning of unresolved or partially resolved preparations of the electrophoretically different forms of the enzyme on the affinity column. Gel filtration and electrophoresis on polyacrylamide gels of increasing concentration revealed no differences in the Mr of these electrophoretically different forms. The four bands resolved by electrophoresis of the different forms on polyacrylamide gels under nondenaturing conditions yielded a single band when electrophoresis was carried out in the presence of sodium dodecyl sulfate and 2-mercaptoethanol. Partially resolved preparations of the different electrophoretic forms of adenosine deaminase also gave rise to a single band of the same mobility when electrophoresed on polyacrylamide gels under these conditions. The band had the mobility of a protein of Mr of 36,000. This Mr is approximately the same as estimated for the nondenatured enzyme.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932020

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency.

Authors:  W P Schrader; B Pollara; H J Meuwissen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

2.  Adenosine deaminase deficiency with normal immune function. An acidic enzyme mutation.

Authors:  P E Daddona; B S Mitchell; H J Meuwissen; B L Davidson; J M Wilson; C A Koller
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

3.  S-Adenosylhomocysteine hydrolase from human placenta. Affinity purification and characterization.

Authors:  M S Hershfield; V N Aiyar; R Premakumar; W C Small
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

Review 4.  Analysis of normal and mutant forms of human adenosine deaminase - a review.

Authors:  P E Daddona; W N Kelley
Journal:  Mol Cell Biochem       Date:  1980-02-08       Impact factor: 3.396

5.  Physical and catalytic properties of the isozymes of adenosine deaminase from human red blood cells.

Authors:  R MacQuarrie; E Buel
Journal:  Mol Cell Biochem       Date:  1982-10-18       Impact factor: 3.396

6.  Basic defect in the expression of adenosine deaminase in ADA-SCID disease. II. Deficiency of ADA-CRM detected in heterozygote human-Chinese hamster cell hybrids.

Authors:  E Herbschleb-Voogt; J W Scholten; P Meera Khan
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

7.  Ecto-enzyme activity of human erythrocyte adenosine deaminase.

Authors:  K Bielat; G L Tritsch
Journal:  Mol Cell Biochem       Date:  1989-04-11       Impact factor: 3.396

8.  Investigation of alpha-deuterium kinetic isotope effects on the purine nucleoside phosphorylase reaction by the equilibrium-perturbation technique.

Authors:  P K Lehikoinen; M L Sinnott; T A Krenitsky
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

9.  [Rat liver S-adenosyl-L-homocysteine hydrolase purification by affinity column chromatography (author's transl)].

Authors:  B Chabannes; L Cronenberger; H Pachéco
Journal:  Experientia       Date:  1979-08-15

10.  Purification, characterization and radioimmunoassay of adenosine deaminase from human leukaemic granulocytes.

Authors:  D A Wiginton; M S Coleman; J J Hutton
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.